Skip to main content
. 2021 Apr 7;11:7599. doi: 10.1038/s41598-021-87149-3

Table 4.

Showed the differences of clinical data between SWS rebounders and non-SWS rebounders.

SWS rebounders n = 164 Non-SWS rebounders n = 337 χ2 p value
Age 46.48 ± 10.49, 46.00 (39.00, 53.00) 51.58 ± 10.94, 51.00 (43.00, 59.00) 0.000***
Sex (Male) 146 (89.6%) 295 (87.5%) 0.509
BMI 30.34 ± 4.20 30.10 (27.77, 32.65) 28.64 ± 3.83 28.28 (26.08, 31.13) 0.000***
ESS 12.30 ± 6.80 11.00 (7.00, 18.00) 10.03 ± 6.75 9.00 (5.00, 14.75) 0.000***
Insomnia 57 (34.76%) 172 (51.04%) 11.786 0.001**
Early insomnia 24 (14.63%) 83 (24.63%) 6.561 0.01*
Middle insomnia 44 (26.83%) 96 (28.49%) 0.15 0.698
Late insomnia 20 (12.20%) 87 (25.82%) 12.185 0.000***
Dizzy 56 (34.14%) 167 (49.55%) 10.604 0.001**
Anxiety 32 (19.51%) 102 (30.27%) 6.513 0.011*
Irritability 42 (25.61%) 118 (35.01%) 4.489 0.034*
Depression 42 (25.61%) 92 (27.30%) 0.161 0.688
Cognition dysfunction 23 (14.02%) 48 (14.24%) 0.004 0.947
Gastric reflux 27 (16.46%) 52 (15.43%) 0.766 0.766
Hyposexuality 45 (27.44%) 83 (24.63%) 0.458 0.499
Fatigue 62 (37.80%) 118 (35.01%) 0.373 0.541
Hypertension 83 (50.61%) 155 (45.99%) 0.942 0.332
Cardiac diseases 23 (14.02%) 43 (12.76%) 0.154 0.694
Diabetes mellitus 15 (9.15%) 29 (8.61%) 0.04 0.841
Legs uncomfortable 43 (26.22%) 86 (25.52%) 0.028 0.866
Stroke 10 (6.10%) 18 (5.34%) 0.12 0.729